52-WEEK RESULTS Statistically significant A1C control vs Jardiance 2* Sustainable A1C control demonstrated at 52 weeks *Endpoint not adjusted for multiplicity
It is important to only take these medications when necessary
Glucagon-like peptide-1 receptor agonists, aka GLP-1 drugs, were originally approved and used for treatment of Type 2 diabetes, with the first product debuting in 2005
Joe Nadglowski President & CEO, Obesity Action Coalition #ObesityCare #Medicare #GLP1 #HealthPolicy #OAC #OCAN To view or add a comment, sign in 222,286 followers
Recipients are responsible for compliance with all applicable institutional, state, and federal regulations
You can take GLP-1 medications at any time during the day, without regard to meals